TARS Tarsus Pharmaceuticals Inc
409
$35.70
$0.46
(1.27%)
| Watchers | 409 |
| 52-Wk Low | $12.57 |
| 52-Wk High | $42.50 |
| Market Cap | $1.37B |
| Volume | 101,051.00 |
| 52-Wk High | $42.50 |
| 52-Wk Low | $12.57 |
Analyst Ratings For Tarsus PharmaceuticalsBenzinga • 15 days ago
Latest Ratings for TARS
DateFirmActionFromTo Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Nov 2021OppenheimerInitiates Coverage OnOutperform Oct 2021Raymond JamesMaintainsStrong Buy...
Share to Feed
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eight research firms that are presently covering the stock, MarketBeat...
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS Get Free Report) General Counsel Bryan Wahl sold 4,436 shares of the firms stock in a transaction dated Monday, March 18th. The stock was sold...
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS Get Free Report) COO Seshadri Neervannan sold 4,879 shares of the companys stock in a transaction dated Monday, March 18th. The shares were...
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS Get Free Report) rose 6.9% on Friday . The stock traded as high as $31.73 and last traded at $31.47. Approximately 103,785 shares changed...
This indicator may be signaling that TARS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tarsus Pharmaceuticals: A Strong Launch For An Under The Radar Name...
IRVINE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Unique and memorable campaign intended to educate consumers about Demodex blepharitis and XDEMVY, the first and only FDA approved solution for the disease Demodex blepharitis impacts approximately...